Dr. Reddy's intros generic NitropressThe Nitropress brand and generics had a market value of approximately $8 million for the most recent 12 months ended October 2019. Lupin gets FDA OK for generic Myfortic, launches generic HectorolMycophenolic acid delayed-release tablets and doxercalciferol injection had a market value of roughly $174 million and $132 million, respectively. Amneal names 3 executives to its board of directors Jeff George, John Kiely and Shlomo Yanai have been appointed to Amneal’s board of directors. E5 Pharma launches generic Proglycem e5 Pharma's diazoxide oral suspension is the first generic of Proglycem. Lupin gets FDA OK for generic Diprolene Betamethasone dipropionate ointment had a market value of roughly $22 million, according to IQVIA September 2019 data. Fresenius Kabi debuts generic Bentyl Fresenius Kabi's generic Bentyl is available in a 20 mg per 2 mL single-dose vial. Redmond & Greer to become Mockingbird Pharma Mockingbird Pharma will replace the name Redmond & Greer as of Jan. 1, 2020. House Appropriations Committee passes CREATES Act The CREATES Act would stop drugmakers from limiting access to brand and biologic drugs necessary for generic and biosimilar drug development. FDA gives Zydus Cadila's generic Belviq tentative approval Zydus Cadila's generic Belviq is used together with diet and exercise to treat obesity. Prasco launches authorized generic NuvaRing In partnership with Merck, Prasco is launching an authorized generic of NuvaRing. First Previous 152 153 154 155 156 Next Last